MSD is paying $20 million upfront to activate an alliance with Flagship Pioneering's Quotient Therapeutics that will focus on finding new therapeutic targets in inflammatory bowel disease (IBD). The ...
After generating interest from the likes of Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted another Big Pharma suitor in Merck & Co. Looking to devise new drug targets ...
Databricks Inc. today introduced Genie Code, an artificial intelligence agent designed to automate complex data engineering and analytics tasks. The move extends the rapid evolution of agents from ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Quotient AI was founded in 2023 ...
AI on the JVM accelerates: New frameworks like Embabel, Koog, Spring AI, and LangChain4j drive rapid adoption of AI-native and AI-assisted development in Java. Java 25 anchors a modern baseline: The ...
With the fund, India Quotient aims to back pre-seed, seed stage Indian startups along with investing in idea stage startups Vice president Sahil Makkar and ex-Upside AI cofounder Kanika Agarrwal have ...
Sherre DeMao is CEO of BizGrowth Inc., a strategy, training and IP development firm focused on growing entrepreneurial enterprise value. “Too big to fail” was a term used during the Great Recession ...
Happy Birthday, Java! Even as rivals Python and Rust claim the spotlight, proponents say the 30-year-old language will continue to forge ahead. Introduced by Sun Microsystems on May 23, 1995, Java is ...
GameSpot may get a commission from retail offers. While you may be limited to which version of Minecraft you can play based on the device you're using, there are some important differences between ...
Quotient Sciences, a CDMO, reports that it has installed Centillion’s™ Biofoundry-in-a-Box (BiaB™), a multi-product GMP platform technology for end-to-end RNA manufacture. BiaB is a modular, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results